Do neuraminidase inhibitors prevent influenza?
Husereau
D R
DR
Canadian Coordinating Office for Health Technology Assessment.
D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D002170:Canada; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control*; D009439:Neuraminidase / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000191:economics / Q000627:therapeutic use; D012794:Sialic Acids / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D013673:Technology Assessment, Biomedical
D000998:Antiviral Agents; D012794:Sialic Acids; D000547:Amantadine; D009439:Neuraminidase